Skip To Main Content
Nicole Wetsman on Muck Rack

Nicole Wetsman

Verified
  • Deputy Editor, Events and Special Projects, Endpoints News
  • None, Endpoints
New York
As seen in: Endpoints News, MSN, MSN Australia, MSN Canada, MSN Malaysia, OneZero, UOL, Business Insider, Nature, The Wall Street Journal, Yahoo Canada and
deputy editor for events & special projects @endpts | formerly @ABC med unit & @verge | mostly soccer tweets

Get in touch with Nicole

Contact Nicole, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Nicole Wetsman’s Journalist Portfolio

We're Not Really Sure How to Assess the Concussions of Athletes With Learning Disabilities

We're Not Really Sure How to Assess the Concussions of Athletes With Learning Disabilities

Despite what many of last month's headlines announcing the "concussion blood test" might have you believe, do…

View article →

Articles

Michael Gilman retires as Arrakis CEO; Daniel Skovronsky joins Illumina's board of directors

|
By Nicole Wetsman Verified, Max Bayer Verified, Kyle LaHucik Verified
| Endpoints News Verified
Stores the user cookie consent preferences. Records which cookie categories have been accepted or rejected. intercom-device-id-tc3tuo04 Assigns a unique ID to the device to maintain Intercom Messenger chat sessions and user preferences across visits. intercom-session-tc3tuo04 Stores the current Intercom Messenger session data. Maintains chat conversation state between page loads. Stores a unique Intercom Messenger user identifier. Allows the chat widget to recognise returning visitors across sessions.
Open in Who Shared View Duplicates (7) Issue with article?

Some research shows patients don’t stick with GLP-1s for long. Amazon Pharmacy and Ro say they're changing that

|
By Nicole Wetsman Verified
| Endpoints News Verified
Patients who get their GLP-1 weight loss medication prescriptions filled at Amazon Pharmacy are more likely to keep taking the medications than other published research … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?

‘It’s not right.’ Califf slams pharma over weight loss drug prices

|
By Nicole Wetsman Verified
| Endpoints News Verified
LAS VEGAS — FDA Commissioner Robert Califf criticized pharma companies on Monday for charging high prices for weight loss drugs. Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?
See all 1,040 licensed articles (1,247 Total)